SMYD2 overexpression is associated with the proliferation and poor prognosis of human non-papillomavirus-related head and neck cancer tumor cells [11], cell proliferation of esophagus and squamous cell carcinoma [20], and the incidence of cervical cancer [21]. Here, SMYD2 is linked to cervical carcinoma.